# Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma

> **NCT00019123** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00019123
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-04
- **Primary completion:** —
- **Final completion:** 2004-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00019123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00019123, "Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00019123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*